TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 26 filers reported holding TITAN PHARMACEUTICALS INC DE in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $29,000 | – | 52,108 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 863,512 | $826,000 | 0.02% |
| Level Financial Advisors | 987 | $1,000 | 0.00% |
| Westside Investment Management, Inc. | 4 | $0 | 0.00% |
| BARCLAYS PLC | 50,050 | $48,000 | 0.00% |
| FMR LLC | 1 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 206 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 68 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 7,123 | $7,000 | 0.00% |
| IFP Advisors, Inc | 844 | $3,000 | 0.00% |